EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

HCC Summit 2019

 

14-16 February 2019 Lisbon
Close
N. Poster
Poster title
Applicant name
Status
  P06-02 HCC recurrence after DAA treatment in HCV patients. Maria Guarino Received Received
  P04-04 Oncological long term benefit in case of anatomic versus parenchyma-sparing resection for hepatocarcinoma: does the extension matter? A meta-analysis of high quality propensity matched and randomized studies. Simone Famularo Received Received
  P07-06 yttrium -90 trans arterial radioembolisation (tare) is an effective treatment for the downstaging of patients with hepatocellular carcinoma: a monocentric experience in a tertiary center Helene Regnault Received Received
  P03-08 To cure or not to cure intermediate stage hepatocellular carcinoma beyond Milan Criteria: trans-arterial chemoembolization versus surgery in a multicentric matched cohort Simone Famularo Received Received
  P03-09 comparison between rates of hepatitis c-related hepatocellular carcinoma recurrence in patients who received or not direct acting antiviral treatment Hend Shousha Received Received
  P01-11 ESM-1 as a marker of macrotrabecular-massive hepatocellular carcinoma Julien Calderaro Received Received
  P02-12 protein kinase erk5 modulates liver regeneration process in mice Giovanni Di Maira Received Received
  P06-12 survival and prognostic factors of patients with advanced hepatocellular carcinoma and treated with sorafinib Hend Shousha Received Received
  P02-15 hepatocellular carcinoma identification models for patients with hcv-related chronic liver disease using data mining techniques Hend Shousha Received Received
  P05-17 impact of interval between complete ablation of hepatocellular carcinoma and start of direct acting antivirals to manage chronic hepatitis C infection Hend Shousha Received Received
  P01-17 genetic variation in death receptor domain 4 (DR4) gene and the susceptibility to hepatitis-c related hepatocellular carcinoma Hend Shousha Received Received
  P02-17 mtdh/aeg-1/lyric promotes tumor proliferation and targeted drug resistance in hepatocellular carcinoma Shunjie Xia Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:30, Fri 8:30-15:00
10:25
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
Captcha image
 

EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

HCC Summit 2019

 

14-16 February 2019 Lisbon
HELP LINE
Manage Orders
FAQs


Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 14/02/2019 TO 14/02/2020
Poster
Gallery
Oral Presentation
& Video Gallery
Poster Discussion
Forum
                  
PrintingOnline
Submit your poster online
in powerpoint format

   Poster submission deadline 06/02/2019
Upload Poster
Upload Oral Presentation of Video
Upload
Poster
Upload Oral
Presentation or Video




PosterSessionOnline
Logo Draft
 
Logo Cert